Citius Pharmaceuticals, Inc. (CTXR) DCF Valuation

Citius Pharmaceuticals, Inc. (CTXR) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Citius Pharmaceuticals, Inc. (CTXR) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Citius Pharmaceuticals, Inc. (CTXR) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Descubra Citius Pharmaceuticals, Inc. (CTXR) Valor verdadero con nuestra calculadora DCF avanzada! Ajuste los supuestos esenciales, explore varios escenarios y evalúe cómo los diferentes factores influyen en la valoración de Citius Pharmaceuticals, Inc. (CTXR), todo dentro de una plantilla de Excel integral.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -17.4 -22.9 -32.9 -36.7 .0 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .2 .2 .2 .2 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -17.5 -23.0 -33.1 -36.9 .0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 13.9 70.1 41.7 26.5 3.3 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 8.3 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.9 1.3 1.2 2.9 4.9 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -40.0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % -1.48 -1.48 -1.48 -1.48 -1.48 -1.48 -1.48 -1.48 -1.48 -1.48
EBITAT -17.7 -23.1 -33.6 -37.6 .0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -15.7 -63.5 -33.6 -35.6 -6.3 3.3 .0 .0 .0 .0
WACC, % 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45
PV UFCF
SUM PV UFCF 3.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 3
Net Debt -3
Equity Value 6
Diluted Shares Outstanding, MM 151
Equity Value Per Share 0.04

What You Will Get

  • Pre-Filled Financial Model: Citius Pharmaceuticals' actual data facilitates accurate DCF valuation.
  • Full Forecast Control: Modify revenue growth, margins, WACC, and other essential drivers.
  • Instant Calculations: Automatic updates provide immediate results as you adjust inputs.
  • Investor-Ready Template: A polished Excel file crafted for professional-level valuation.
  • Customizable and Reusable: Designed for adaptability, allowing repeated application for comprehensive forecasts.

Key Features

  • 🔍 Real-Life CTXR Financials: Pre-filled historical and projected data for Citius Pharmaceuticals, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Citius Pharmaceuticals’ intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Citius Pharmaceuticals’ valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Obtain the comprehensive Excel file containing Citius Pharmaceuticals, Inc.'s (CTXR) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC to fit your analysis.
  • Update Automatically: Watch as intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and instantly compare the results.
  • Make Decisions: Leverage the valuation outcomes to inform your investment choices.

Why Choose This Calculator for Citius Pharmaceuticals, Inc. (CTXR)?

  • Accurate Data: Utilize real Citius Pharmaceuticals financials for dependable valuation outcomes.
  • Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations save you from starting from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the pharmaceutical sector.
  • User-Friendly: Simple design and clear instructions ensure accessibility for all users.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive and accurate valuation models for Citius Pharmaceuticals, Inc. (CTXR) portfolio assessments.
  • Pharmaceutical Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
  • Consultants and Advisors: Deliver precise valuation insights to clients interested in Citius Pharmaceuticals, Inc. (CTXR).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech firms like Citius Pharmaceuticals, Inc. (CTXR) are valued in the market.

What the Template Contains

  • Historical Data: Includes Citius Pharmaceuticals' past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Citius Pharmaceuticals' intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Citius Pharmaceuticals' financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.